Ladder Capital Corp (LADR)

Ligand Pharmaceuticals Revenue

Ladder Capital had revenue of $56.30M in the quarter ending June 30, 2025, a decrease of -21.44%. This brings the company's revenue in the last twelve months to $243.79M, down -6.41% year-over-year. In the year 2024, Ladder Capital had annual revenue of $271.18M with 6.98% growth.

• Revenue (ttm): $243.79M
• Revenue Growth: -6.41%
• P/S Ratio: 5.69
• Revenue / Employee: $4,514,704
• Employees: 54
• Market Cap: 1.41B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	271.18M	17.69M	6.98%
Dec 31, 2023	253.50M	-91.10M	-26.44%
Dec 31, 2022	344.59M	160.98M	87.68%
Dec 31, 2021	183.61M	71.81M	64.23%
Dec 31, 2020	111.81M	-188.55M	-62.78%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.